{"id":"W2757588171","doi":"10.1016/j.cjca.2017.07.224","title":"ON-TREATMENT LDL-C LEVELS WHEN ALIROCUMAB DOSE IS DECREASED FROM 150 TO 75 MG EVERY 2 WEEKS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM ODYSSEY","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Alirocumab; Cohort; Placebo; Internal medicine; Statin; Population; Gastroenterology; Familial hypercholesterolemia; Cholesterol; Apolipoprotein B","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000569793,0.0004651341,0.001097835,0.0001611984,0.0002815003,0.0004686981,0.0002983061,0.0004436721,0.0009543879],"category_scores_gemma":[0.001073691,0.0002612633,0.001654952,0.0002267457,0.0003462432,0.0004181078,0.0003046316,0.001026875,0.0001517024],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008015194,"about_ca_system_score_gemma":0.0007620753,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006373392,"about_ca_topic_score_gemma":0.01085068,"domain_scores_codex":[0.9997447,0.0000686845,0.00002281838,0.00006143302,0.00004503697,0.0000573666],"domain_scores_gemma":[0.9995647,0.0001099896,0.0000877143,0.0000337552,0.00005108768,0.0001527021],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5071188,0.00810542,0.3305595,0.0008093226,0.004800035,0.0009211674,0.0005507786,0.0007746498,0.01369436,0.0002120617,0.00537388,0.12708],"study_design_scores_gemma":[0.05099272,0.04012606,0.8939232,0.000137995,0.005898517,0.0009307943,0.0004976821,0.001216099,0.001935982,0.0002670645,0.003981125,0.00009284289],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997364,0.001184199,0.00006569346,0.0002232105,0.0000324391,0.00003082848,0.0004221334,0.00001048818,0.0006669863],"genre_scores_gemma":[0.9967258,0.001089872,0.000428048,0.0004503995,0.0000599816,0.00003465366,0.0006942097,0.000007647311,0.0005093231],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006373392,"threshold_uncertainty_score":0.0126726,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0242300489803855,"score_gpt":0.252160225599999,"score_spread":0.2279301766196135,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}